Metraipolis › archive › dc_610f91bbceda

Digital assessment in myasthenia gravis: evidence, validation, and a proposed framework for autoimmune heterogeneity, remote monitoring, and clinical endpoints — Europe PMC PMID:42756700

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42756700
DOI: 10.3389/fimmu.2026.1948530
License (as archived): solo-consultazione
Archived: 2026-10-08T05:37:13.349Z
SHA-256 of the archived text: 3685be554928dfc22d35ac7e3869c94e0a9aa1328719d09cda0472219e823189
Stable URL of this page: https://metraipolis.com/documento/dc_610f91bbceda

How to cite

Digital assessment in myasthenia gravis: evidence, validation, and a proposed framework for autoimmune heterogeneity, remote monitoring, and clinical endpoints — Europe PMC PMID:42756700 — Europe PMC (en), https://europepmc.org/article/MED/42756700 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_610f91bbceda (Metraipolis archive dc_610f91bbceda, sha256 3685be554928dfc22d35ac7e3869c94e0a9aa1328719d09cda0472219e823189)

BibTeX

@misc{dc610f91bbceda,
  title = {Digital assessment in myasthenia gravis: evidence, validation, and a proposed framework for autoimmune heterogeneity, remote monitoring, and clinical endpoints — Europe PMC PMID:42756700},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42756700},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_610f91bbceda; sha256 3685be554928dfc22d35ac7e3869c94e0a9aa1328719d09cda0472219e823189},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42756700. Agents can read the archived copy with the MCP tool read_document.